Globeflex Capital L P acquired a new stake in OraSure Technologies, Inc. (NASDAQ:OSUR – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 312,393 shares of the medical instruments supplier’s stock, valued at approximately $1,890,000. Globeflex Capital L P owned 0.41% of OraSure Technologies at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently modified their holdings of the company. Advisor Group Holdings Inc. increased its position in OraSure Technologies by 12.0% during the first quarter. Advisor Group Holdings Inc. now owns 20,720 shares of the medical instruments supplier’s stock worth $163,000 after buying an additional 2,225 shares during the last quarter. Swiss National Bank raised its stake in OraSure Technologies by 7.7% in the 1st quarter. Swiss National Bank now owns 170,300 shares of the medical instruments supplier’s stock valued at $1,155,000 after acquiring an additional 12,200 shares during the period. JPMorgan Chase & Co. raised its stake in OraSure Technologies by 22.8% in the 1st quarter. JPMorgan Chase & Co. now owns 67,370 shares of the medical instruments supplier’s stock valued at $457,000 after acquiring an additional 12,505 shares during the period. Citigroup Inc. lifted its holdings in OraSure Technologies by 9.4% during the 1st quarter. Citigroup Inc. now owns 82,512 shares of the medical instruments supplier’s stock valued at $559,000 after purchasing an additional 7,103 shares during the last quarter. Finally, MetLife Investment Management LLC boosted its position in OraSure Technologies by 51.2% during the first quarter. MetLife Investment Management LLC now owns 43,288 shares of the medical instruments supplier’s stock worth $293,000 after purchasing an additional 14,653 shares during the period. 88.76% of the stock is owned by institutional investors.
OraSure Technologies Stock Performance
OSUR stock opened at $6.04 on Friday. OraSure Technologies, Inc. has a 52 week low of $3.45 and a 52 week high of $7.82. The company has a market capitalization of $443.46 million, a PE ratio of 10.41 and a beta of 0.03. The company’s 50-day simple moving average is $5.58 and its 200 day simple moving average is $5.88.
Wall Street Analysts Forecast Growth
A number of analysts have recently issued reports on OSUR shares. TheStreet cut shares of OraSure Technologies from a “c” rating to a “d+” rating in a research note on Friday, August 4th. Stephens reduced their price objective on OraSure Technologies from $6.50 to $5.00 in a report on Monday, July 17th. Finally, StockNews.com lowered OraSure Technologies from a “buy” rating to a “hold” rating in a research note on Monday, September 4th.
About OraSure Technologies
OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions.
- Five stocks we like better than OraSure Technologies
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- MarketBeat Week in Review – 9/4 – 9/8
- Stock Analyst Ratings and Canadian Analyst Ratings
- The Best 5 Small Cap AI Companies to Buy Now
- What Are Defense Contractor Stocks? How to Invest in Defense
- Miso Robotics Stock: Is an IPO Coming Soon?
Receive News & Ratings for OraSure Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies and related companies with MarketBeat.com's FREE daily email newsletter.